Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1695 clinical trials
Effects of Brain Stimulation on Cognition Oscillations and GABA Levels in Schizophrenia

This study has three main goals: (1) To compare the effects of task-engaged versus resting tDCS in order to optimize the impact of tDCS on goal maintenance related neural oscillatory activity and task performance in schizophrenia; (2) To establish the regional specificity of the impact of DLPFC tDCS (compared to …

transcranial direct current stimulation
task performance
schizophrenia
clozapine
brain stimulation
  • 0 views
  • 16 Feb, 2024
  • 1 location
Nivolumab Ipilimumab and Chemoradiation in Treating Patients With Locally Advanced Pancreatic Cancer.

A locally unresectable tumor (locally advanced pancreatic cancer (LAPC)) is present in 30% of the cases and is defined as a surgically unresectable tumor encasing the adjacent arteries [celiac axis, superior mesenteric artery (SMA)]. In these patients, chemotherapy has been the standard treatment for decades, optionally combined with radiotherapy.

immunosuppressant
chemoradiotherapy
serum bilirubin level
teratogenicity
gilbert's syndrome
  • 0 views
  • 16 Feb, 2024
  • 1 location
SBRT for Breast Cancer Oligometastases

If functional imaging (bone scan, PET) were used at staging, changes in the uptake will be used in follow up scans to determine response to treatment and progression. As for SBRT related morbidities, we will use the Common Terminology Criteria for Adverse Events (CTCAE v5) for toxicity reporting and scoring.

bone metastases
solid tumor
positron emission tomography
metastasis
breast cancer
  • 0 views
  • 05 Aug, 2020
Performance of CAD/CAM Milled and 3D-printed Full-arch Implant-supported Provisionals Restorations

The main question it aims to answer is if there are differences in the mechanical behavior and optical properties of the materials used as provisional materials in full-arch restorations on implants fabricated by CAD/CAM technology through machining or 3D printing. Participants will: Receive milled (control material: PMMA; Multilayer PMMA block, …

Accepts healthy volunteers
  • 0 views
  • 02 Mar, 2026
  • 1 location
CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

Six doses of rituximab and will be monitored the week 5 MRD and relapse rate as study outcome. Adding bortezomid during the consolidation:The very early or early bone marrow relapse has low remission rate.

remission
bortezomib injection
hematopoietic stem cell transplantation
acute lymphoblastic leukemia
cns involvement
  • 0 views
  • 16 Feb, 2024
  • 1 location
Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT

The number and clinical lifespan of stents implanted over the last twenty-five years, however, explain the fact that restenosis remains a not unusual clinical problem which is expressed as a recurrence of angina or of an acute coronary syndrome (ACS). The mechanisms involved in this restenosis are multifactorial in nature …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Reduction of COVID 19 Transmission to Health Care Professionals

The pulmonary epithelial cells of a part of the population, known as "secretors", are capable of expressing the antigens of the "ABO" system on their surface. This secretory status can be established by determining the antigens of the Lewis blood group system.

epithelial cells
  • 0 views
  • 16 Feb, 2024
  • 1 location
NoIAmNot Trial

The dose of 1-5 x 10xE8 T-cells in Stage 2 will be administered via split dosing: 10% on Day 1 (1-5x10xE7), 30% on Day 2 (3x107-1.5x10xE8), 60% on Day 3 (6x107-3x10xE8). Evaluable subjects are defined as those who were able to receive the viable product at the intended dose level …

  • 0 views
  • 21 Feb, 2023
enrolling Trial

The dose of 1-5 x 10xE8 T-cells in Stage 2 will be administered via split dosing: 10% on Day 1 (1-5x10xE7), 30% on Day 2 (3x107-1.5x10xE8), 60% on Day 3 (6x107-3x10xE8). Evaluable subjects are defined as those who were able to receive the viable product at the intended dose level …

  • 0 views
  • 22 Feb, 2023
COPD-ICU Multicentre Prospective Observational Register (COPD-ICU)

The dose of 1-5 x 10xE8 T-cells in Stage 2 will be administered via split dosing: 10% on Day 1 (1-5x10xE7), 30% on Day 2 (3x107-1.5x10xE8), 60% on Day 3 (6x107-3x10xE8). Evaluable subjects are defined as those who were able to receive the viable product at the intended dose level …

  • 0 views
  • 21 Feb, 2023